MARKER GENE TECHNOLOGIES INC — SBIR/STTR Competitive Profile
Aggregate SBIR/STTR award history for MARKER GENE TECHNOLOGIES INC, built entirely from public federal award records. Free competitive intelligence — no login required.
- 4 awards
- $3,005,014 total on record
- 1 agency
- 2 Phase I · 2 Phase II
Phase mix
- Phase I — 2 awards
- Phase II — 2 awards
Funding agencies
Awards by year
- 2017 — 1 award
- 2015 — 1 award
Places of performance
Firms like MARKER GENE TECHNOLOGIES INC
See the companies with the most overlapping technology domains and funding agencies, ranked by a weighted-overlap similarity score.
Sign in to see firms like this
The full similar-firms list is free with an account. Sign in or create a free account to compare competitors.
Recent awards
| Award | Agency | Amount | Program | Start |
|---|---|---|---|---|
| 2R44GM108137-02 | Department of Health and Human Services | $1,097,123 | SBIR · Phase II | 2017-08-01 |
| 1R43NS092155-01 | Department of Health and Human Services | $224,593 | SBIR · Phase I | 2015-07-01 |
| 2R44NS073225-03A1 | Department of Health and Human Services | $1,533,541 | SBIR · Phase II | — |
| 1R43GM108137-01 | Department of Health and Human Services | $149,757 | SBIR · Phase I | — |
Frequently asked questions
How many SBIR/STTR awards has MARKER GENE TECHNOLOGIES INC won?
MARKER GENE TECHNOLOGIES INC has won 4 SBIR/STTR awards worth $3,005,014 in the public federal award records SBIR Signal tracks, including 2 Phase I and 2 Phase II award(s).
Which agencies fund MARKER GENE TECHNOLOGIES INC?
MARKER GENE TECHNOLOGIES INC's awards come from 1 agency on record; its top funder is Department of Health and Human Services.
What technology areas does MARKER GENE TECHNOLOGIES INC work in?
Based on its award history, MARKER GENE TECHNOLOGIES INC works in a range of technology areas.
How do I find firms similar to MARKER GENE TECHNOLOGIES INC?
Sign in and open the 'firms like this' view on the profile to see the companies with the most overlapping technology domains and funding agencies.